Dr. Mikel Thomas
Claim this profileCollective Medical Research
Studies Childhood Onset Fluency Disorder
Studies Stuttering
1 reported clinical trial
2 drugs studied
Affiliated Hospitals
More about Mikel Thomas
Clinical Trial Related2 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Mikel Thomas has experience with
- NOE-105
- Placebo
Breakdown of trials Mikel Thomas has run
Childhood Onset Fluency Disorder
Stuttering
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mikel Thomas specialize in?
Mikel Thomas focuses on Childhood Onset Fluency Disorder and Stuttering. In particular, much of their work with Childhood Onset Fluency Disorder has involved treating patients, or patients who are undergoing treatment.
Is Mikel Thomas currently recruiting for clinical trials?
No, Mikel Thomas is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Mikel Thomas has studied deeply?
Yes, Mikel Thomas has studied treatments such as NOE-105, Placebo.
What is the best way to schedule an appointment with Mikel Thomas?
Apply for one of the trials that Mikel Thomas is conducting.
What is the office address of Mikel Thomas?
The office of Mikel Thomas is located at: Collective Medical Research, Overland Park, Kansas 66210 United States. This is the address for their practice at the Collective Medical Research.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.